Incidence of Ssi After c.s
Incidence of Surgical Site Infection After Cesarean Section and Compliance With Surgical Site Infection Prevention Stratigies .
1 other identifier
observational
105
1 country
1
Brief Summary
aim of the work is to evaluate adherence to preoperative , intraoperative, and postoperative infection preventive measures during cesarean section and to assess it s impact on the incidence of surgical site infection and maternal well-being during 30 days postoperative peroid.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2026
CompletedFirst Posted
Study publicly available on registry
March 17, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
March 17, 2026
March 1, 2026
1 year
March 12, 2026
March 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
incidence of surgical site infection after cesarean section
superficial or deep surgical site infection
Baseline
Eligibility Criteria
The study population will include all women undergoing Cesarean Section at El-Mabarra Health Insurance Hospital during the study period. Eligible participants will be followed for 30 days after delivery to detect the occurrence of Surgical Site Infection. Women who meet the inclusion criteria and agree to participate in the study will be enrolled consecutively until the required sample size is reached.
You may qualify if:
- All women who underwent cesarean section during the study period
You may not qualify if:
- Patients who are lost to follow-up before completion of the 30-day postoperative assessment.
- Patients with immunocompromised conditions, such as:
- Chronic corticosteroid therapy. Immunosuppressive treatment. Known HIV infection with severe immunosuppression .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
El Mabarra Health Insurance Hospital.
Asyut, Egypt
Related Publications (1)
Naeem A, et al. Incidence of surgical site infection after cesarean section. 2025.
BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor
Study Record Dates
First Submitted
March 12, 2026
First Posted
March 17, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
March 17, 2026
Record last verified: 2026-03